Comparison of Effectiveness and Patient Satisfaction of Vaginal Versus Oral Misoprostol in Treatment of Missed Miscarriage
DOI:
https://doi.org/10.3889/oamjms.2019.192Keywords:
Missed abortion, Oral misoprostol, Patient’s satisfaction, Vaginal misoprostolAbstract
BACKGROUND: In recent years’ medical management with misoprostol is an effective alternative to surgical evacuation. But there is a dearth of evidence to reveal the effectiveness of the different routes of misoprostol and satisfaction rate among the patients treated with these routes.
AIM: This study was conducted to compare the effectiveness and patient’s satisfaction rate of vaginal versus oral misoprostol.
METHODS: It was a prospective non-interventional study. One hundred women of having missed abortion confirmed by ultrasonography examination were enrolled in the trial. Fifty-eight subjects were administered 200 mcg of oral and 42 subjects received 200 mcg of vaginal misoprostol every four hours up to four doses. If complete expulsion did not occur 12 hours after the last dose, the surgical evacuation was done.
RESULTS: There was no significant statistical difference between the effectiveness of treatment with vaginal (78.57%) and oral misoprostol (79.31%) (p = 0.928). The difference between Patients’ satisfaction at the time of discharge for the vaginal group (64.29%) and oral group (65.52%) was not statistically significant (P = 0.991). There was an increase in patients’ satisfaction for both groups at the follow-up session, but still, the difference was not significant (P = 0.897).
CONCLUSION: This study confirms that there is no statistical difference between the effectiveness and patient satisfaction of oral and vaginal misoprostol in the treatment of missed abortion.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Neilson JP, Hickey M, Vazquez JC. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews. 2006(3).
Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). Bmj. 2006; 332(7552):1235-40. https://doi.org/10.1136/bmj.38828.593125.55 PMid:16707509 PMCid:PMC1471967
Gemzellâ€Danielsson K, Ho PC, Gómez Ponce de León R, Weeks A, Winikoff B. Misoprostol to treat missed abortion in the first trimester. International Journal of Gynecology & Obstetrics. 2007; 99(S2). https://doi.org/10.1016/j.ijgo.2007.09.008
Rcoo G. The care of women requesting induced abortion. London: Royal College of Obstetricians and Gynaecologists, 2004.
Gariepy AM, Stanwood NL. Medical management of early pregnancy failure. Contemporary OB/GYN. 2013; 58(5):26.
WHO. WHO model list of essential medicines, 20th list (March 2017, amended August 2017), 2017.
Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstetrics & Gynecology. 2004; 103(5):866-70. https://doi.org/10.1097/01.AOG.0000124783.38974.53 PMid:15121558
El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. New England Journal of Medicine. 1995; 332(15):983-7. https://doi.org/10.1056/NEJM199504133321502 PMid:7885426
Farhadifar F, Shahgheibi S, Moradi G, Memar FM. Comparison of Oral Versus Vaginal Misoprostol for Legal Abortion in Iranian Women. Journal of Clinical Gynecology and Obstetrics. 2016; 5(2):59-63. https://doi.org/10.14740/jcgo406e
Nikcevic AV, Tunkel SA, Nicolaides KH. Psychological outcomes following missed abortions and provision of followâ€up care. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 1998; 11(2):123-8. https://doi.org/10.1046/j.1469-0705.1998.11020123.x PMid:9549839
Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics & Gynecology. 1997; 90(1):88-92. https://doi.org/10.1016/S0029-7844(97)00111-7
Wagaarachchi PT, Ashok PW, Smith NC, Templeton A. Medical management of early fetal demise using sublingual misoprostol. BJOG: An International Journal of Obstetrics & Gynaecology. 2002; 109(4):462-5. https://doi.org/10.1111/j.1471-0528.2002.01075.x PMid:12013170
Behrashi M, Mahdian M, Mosavi GA, Aghdaee S. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial. SSU Journals. 2008; 16(3):316-.
Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstetrics & Gynecology. 1997; 89(5):768-72. https://doi.org/10.1016/S0029-7844(97)81438-X
Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstetrics & gynecology. 1997; 90(5):735-8. https://doi.org/10.1016/S0029-7844(97)00419-5
Shetty J, Pallavi MN. Medical abortion by mifepristone with oral versus vaginal misoprostol. The Journal of Obstetrics and Gynecology of India. 2006; 56(6):529-31.
Marwah S, Gupta S, Batra NP, Bhasin V, Sarna V, Kaur N. A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (Misoprostol) in management of first trimester missed abortion. Journal of clinical and diagnostic research: JCDR. 2016; 10(5):QC14. PMid:27437309 PMCid:PMC4948485
Dey M. Oral misoprostol is an effective and acceptable alternative to vaginal administration for cervical priming before first trimester pregnancy termination. Medical Journal Armed Forces India. 2013; 69(1):27-30. https://doi.org/10.1016/j.mjafi.2012.07.014 PMid:24532930 PMCid:PMC3862374
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Elham Mohammadi, Geetha Jayaprakash, Afshin Shiva, Nader Motallebzadeh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
